Invasive pneumococcal disease in North Queensland, 2001

Authors

  • Susan L Hills Communicable Disease Control, Tropical Public Health Unit - Townsville, Aitkenvale, Queensland
  • Jeffrey N Hanna Communicable Disease Control, Tropical Public Health Unit - Cairns, Queensland
  • Denise Murphy Pneumococcal Reference Laboratory, Queensland Health Scientific Services, Coopers Plains, Queensland

DOI:

https://doi.org/10.33321/cdi.2002.26.49

Keywords:

Streptococcus pneumoniae, antibiotic susceptibility, pneumococcal disease, surveillance, penicillin, cephalosporin

Abstract

This report provides information on the 93 locally-acquired cases of invasive pneumococcal disease (IPD) notified in children and adults in north Queensland in 2001. Indigenous people represented 38 (41%) cases. Almost half (45) of all cases were in children under 15 years of age, 20 (44%) of these were in children less than 2 years of age and 20 (44%) in Indigenous children. Five severe cases of IPD occurred, all in non-Indigenous children under 2 years of age. Nine (10%) of the isolates from cases, mainly in young children, had some level of resistance to penicillin. Pneumococcal vaccination programs (including the Indigenous 'elderly and at-risk' adult program and the paediatric 'Indigenous and medically at-risk' conjugate vaccine program) are in place in Queensland although the vaccine is not currently funded for other at-risk groups. If vaccine recommendations had been adhered to in a timely fashion, two of the cases in children and one third (16) of the cases in adults that occurred in 2001 could potentially have been prevented. Commun Dis Intell 2002;26:520-524.

Downloads

Download data is not yet available.

References

Hanna JN, Young DM, Brookes DL, Dostie BG, Murphy DM. The initial coverage and impact of the pneumococcal and influenza vaccination program for at-risk indigenous adults in Far North Queensland. Aust N Z J Public Health 2001;25:543-546.

Fedson DS. The clinical effectiveness of pneumococcal vaccination: a brief review. Vaccine 1999;17 Suppl 1:S85-S90.

National Health and Medical Research Council. The Australian Immunisation Handbook. 7th ed. Canberra: Australian Government Publishing Service, 2000:183-187.

Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-195.

Fagan RL, Hanna JN, Messer RD, Brookes DL, Murphy DM. The epidemiology of invasive pneumococcal disease in children in Far North Queensland. J Paediatr Child Health 2001;37:571-575.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-409.

Hanna JN, Gratten M, Tiley SM, Brookes DL, Bapty G. Pneumococcal vaccination: an important strategy to prevent pneumonia in Aboriginal and Torres Strait Island adults. Aust N Z J Public Health 1997;21:281-285.

Downloads

Published

31/12/02

How to Cite

Hills, Susan L, Jeffrey N Hanna, and Denise Murphy. 2002. “Invasive Pneumococcal Disease in North Queensland, 2001”. Communicable Diseases Intelligence 26 (December):505-19. https://doi.org/10.33321/cdi.2002.26.49.

Issue

Section

Original article

Categories

Most read articles by the same author(s)

1 2 3 > >>